Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 03, 2022 14:19 ET | Source: Talonvest Capital, Inc.

Talonvest Adds More Professionals & Negotiates $33M Life Company Perm Loan for Portfolio

IRVINE, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Talonvest Capital, Inc. and Crist Property Company are proud to announce the recent closing of $33,000,000 in permanent financing for the refinance...
August 03, 2022 12:00 ET | Source: Ovenue

Ovenue launches Real-World Asset management, Tokenization, and Financing platform powered by Artificial Intelligence and Blockchain Technology

San Francisco, California , Aug. 03, 2022 (GLOBE NEWSWIRE) -- Ovenue Inc. which develops state-of-the-art deep technology solutions for valuation and financing of real-world assets for B2B and...
August 03, 2022 09:58 ET | Source: National Down Syndrome Society

The National Down Syndrome Society launches a PSA for Down syndrome awareness and Buddy Walk events across the country

Washington D.C., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Since 1995, community groups and local Down syndrome organizations across the country have gathered each year as part of the National Buddy Walk®...
August 01, 2022 13:34 ET | Source: ReportLinker

The Global Animal Cage Market is expected to grow by $ 1262.98 th during 2022-2026, accelerating at a CAGR of 4.97% during the forecast period

New York, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Animal Cage Market 2022-2026" - https://www.reportlinker.com/p06310880/?utm_source=GNW 97%...
August 01, 2022 09:00 ET | Source: HSLDA

James R. Mason Becomes President of Home School Legal Defense Association (HSLDA)

Purcellville, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Purcellville, VA – James R. Mason has been named president of Home School Legal Defense Association (HSLDA) today after the retirement of the...
August 01, 2022 07:00 ET | Source: Avalo Therapeutics

Avalo Therapeutics Transfers Anti-IL-18 Antibody, AVTX-007 (camoteskimab) to Apollo Therapeutics

Avalo to receive an approximately $15 million upfront payment, up to $74 million in milestone payments.Apollo to lead continued clinical development of AVTX-007, currently in Phase 1b ROCKVILLE, Md....
July 29, 2022 17:00 ET | Source: Hopebridge

Hopebridge Autism Therapy Centers foster friendships between children receiving care and their families

Indianapolis, July 29, 2022 (GLOBE NEWSWIRE) -- Two mothers of children receiving care at Hopebridge Autism Therapy Centers have shared how their families fostered a friendship through their sons’...
July 27, 2022 02:00 ET | Source: NSR

NSR’s Satellite Capacity Report Sees Industry Moving Past COVID-19 Contraction to Drive $207B in Revenue Amidst Competition, Innovation and Risk-Taking

CAMBRIDGE, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- NSR’s Global Satellite Capacity Supply & Demand, 19th Edition (GSCSD19) takes a deep dive into an industry now past the COVID-19 contraction...
July 26, 2022 12:30 ET | Source: Associa

Niki Gloder Joins Associa Real Property Management As Vice President of Operations

DUBLIN, OH, July 26, 2022 (GLOBE NEWSWIRE) -- Associa Real Property Management (RPM), a leading provider of top-tier community management services throughout the Dublin and Mason areas, is pleased...
July 26, 2022 08:00 ET | Source: CinCor Pharma, Inc.

CinCor Pharma Announces Last Patient Randomized in Phase 2 HALO Trial and Initiation of Long-Term Extension Study for Baxdrostat, a Selective Aldosterone Synthase Inhibitor, in Uncontrolled Hypertension

Open Label Extension Study Will Evaluate Baxdrostat for Up to 52 Weeks Topline Data for Phase 2 HALO Trial Expected in 2H 2022 Topline Data for Phase 2 BrigHtn Trial Expected in August 2022 ...